Cardiovascular Diseases

October 24, 2020

The legislation follows an investigation that highlighted how minorities experience much higher rates of lower limb amputation than whites.

October 14, 2020

Flu increases the risk of heart attack, especially among people with diabetes and atherosclerotic cardiovascular disease (ASCVD). COVID-19 and the possibility of co-infection makes getting vaccinated against the flu particularly important this year.

October 14, 2020

Sodium glucose co-transporter 2 (SGLT2) inhibitors have already remade the diabetes drug market. Now competition for new cardiac and renal indications is heating up among three of the main drugs in the class: Janssen’s Invokana (canagliflozin), AstraZeneca’s Farxiga (dapagliflozin), and Eli Lilly/Boehringer-Ingelheim’s Jardiance (empagliflozin).

October 04, 2020

An immunotherapy combination gets a third thoracic indication; another potential indication for an SGLT2 inhibitor.

September 16, 2020

Patient navigators, following an algorithm and using telephone calls to contact patients, improved ACE inhibitor and beta blocker usage among heart failure patients.

September 02, 2020

The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.

September 02, 2020

A study from the European Society of Cardiology answers a question about COVID-19: should patients keep taking well-known heart medications?

August 31, 2020

Findings presented at the European Society of Cardiology meeting could open the door to the use of the gout drug as a treatment targeting the underlying inflammation of cardiovascular disease.

August 26, 2020

SGLT2 inhibitors, GLP-1 receptor agonists also tackle cardiovascular disease, renal failure.

August 01, 2020

COVID-19 spotlights the threat that cardiovascular disease poses to Americans; new technology may help address risk factors at the population health level.

July 26, 2020

Study allays some concern that high-deductible health plans cause people to put off care, although authors urge caution in interpreting the results.

July 25, 2020

Dr. Deepak Bhatt presents results that show Vascepa cuts the risk for surgeries to restore blood flow to the heart by a third.

June 16, 2020

Results from REDUCE-IT trial presented at the ADA meeting show that the fish-oil pill is associated with cardiovascular disease protection among patients with diabetes.